![Edwin Wagena](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edwin Wagena
Amministratore Delegato presso Sutura Therapeutics Ltd.
Posizioni attive di Edwin Wagena
Società | Posizione | Inizio | Fine |
---|---|---|---|
Sutura Therapeutics Ltd.
![]() Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021. | Direttore/Membro del Consiglio | 01/11/2021 | - |
Amministratore Delegato | 01/11/2021 | - |
Storia della carriera di Edwin Wagena
Precedenti posizioni note di Edwin Wagena
Società | Posizione | Inizio | Fine |
---|---|---|---|
Abbott Healthcare Products BV
![]() Abbott Healthcare Products BV Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Healthcare Products BV is a Dutch company that manufactures and distributes pharmaceuticals. The company is based in Weesp, Netherlands. | Corporate Officer/Principal | - | - |
Astellas Pharma Europe BV | Corporate Officer/Principal | - | - |
Kiadis Pharma BV
![]() Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Kiadis Pharma BV operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialisation of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. Its products include: ATIR101 and ATIR201. The firm’s products are based on hematopoietic blood-forming stem cell transplants from donors. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Corporate Officer/Principal | 18/07/2011 | - |
Formazione di Edwin Wagena
Maastricht University | Doctorate Degree |
Statistiche
Distribuzione geografica
Paesi Bassi | 5 |
Regno Unito | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Director/Board Member | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Kiadis Pharma BV
![]() Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Kiadis Pharma BV operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialisation of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. Its products include: ATIR101 and ATIR201. The firm’s products are based on hematopoietic blood-forming stem cell transplants from donors. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Abbott Healthcare Products BV
![]() Abbott Healthcare Products BV Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Healthcare Products BV is a Dutch company that manufactures and distributes pharmaceuticals. The company is based in Weesp, Netherlands. | Health Technology |
Astellas Pharma Europe BV | |
Sutura Therapeutics Ltd.
![]() Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021. | Commercial Services |
- Borsa valori
- Insiders
- Edwin Wagena
- Esperienza